Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target?

INTRODUCTION: The prognosis of multiple myeloma is still unfavorable due to inherent characteristics of the disease and the often-delayed diagnosis due to widespread and unspecific symptoms such as back pain and fatigue. Therefore, a simple diagnostic blood test would be helpful to speed up the diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiner, N., Hajek, R., Nachbaur, D., Borjan, B., Sevcikova, S., Göbel, G., Gunsilius, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369456/
https://www.ncbi.nlm.nih.gov/pubmed/30809317
http://dx.doi.org/10.1155/2019/1806034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369456/
https://www.ncbi.nlm.nih.gov/pubmed/30809317
http://dx.doi.org/10.1155/2019/1806034

Ejemplares similares